Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00123110 · ClinicalTrials.gov registry record · Phase 2
Insulin Resistance and Testosterone in Women
A Phase 2 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 2
- Development phase
- 35
- Enrollment target
NCT00123110: Completed Phase 2 study, sponsored by University of Pennsylvania.
NCT00123110 is a Phase 2 study that has completed, run by University of Pennsylvania. The registered enrollment target is 35 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (74% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00123110, a Phase 2 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine if a relationship between insulin resistance (IR) and testosterone (T) exists in women who have already gone through menopause.
Primary Outcome
Percent change in free T by equilibrium dialysis between baseline and 12 weeks
Interventions
- DRUG metformin
- DRUG placebo pill
- DRUG leuprolide injection
- DRUG placebo injection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2005-07 |
| Est. Completion | 2011-12 |
| Phase | Phase 2 |
What the finished NCT00123110 record still lists
NCT00123110 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (74% lower).
The record links to 0 conditions, and to 4 interventions - of which metformin is the first listed.
NCT00123110 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00123110 about?
NCT00123110 is a clinical study titled "Insulin Resistance and Testosterone in Women". The purpose of this research study is to determine if a relationship between insulin resistance (IR) and testosterone (T) exists in women who have already gone through menopause.
What is the current status of trial NCT00123110?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 35 participants. The study started on 2005-07. Estimated completion is 2011-12.
What interventions are being tested in trial NCT00123110?
The interventions under investigation include: metformin (DRUG), placebo pill (DRUG), leuprolide injection (DRUG), placebo injection (DRUG).
Who is sponsoring clinical trial NCT00123110?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00123110's enrollment target sits among peer trials
35 1524th of 2000 higher than 462 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia